Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Brain : a journal of neurology

• Publication date

  2009-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/brain/awp115PMID 19502294PMCID PMC2724916
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Magnetic resonance imaging findings of leg musculature in Charcot-Marie-Tooth disease type 2 due to dynamin 2 mutation

  2008cited by this paper
• Centronuclear (myotubular) myopathy

  2008cited by this paper
• Dynamin 2-related centronuclear myopathy: clinical, histological and genetic aspects of further patients and review of the literature.

  2008cited by this paper
• A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: clinical and pathological findings.

  2008influential reference
• Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset

  2007cited by this paper
• Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation.

  2007cited by this paper
• Two novel mutations in dynamin-2 cause axonal Charcot–Marie–Tooth disease

  2007cited by this paper
• Intermediate forms of Charcot-Marie-Tooth neuropathy

  2006cited by this paper
• Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy

  2006cited by this paper
• Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease

  2005influential reference
• Mutations in dynamin 2 cause dominant centronuclear myopathy.

  2005cited by this paper
• Charcot-Marie-Tooth disease: an update

  2004cited by this paper
• Phenotypic clustering in MPZ mutations.

  2004cited by this paper
• Charcot-Marie-Tooth disease: study of a large kinship with an intermediate form

  2004cited by this paper
• Dynamin 2 binds gamma-tubulin and participates in centrosome cohesion.

  2004cited by this paper
• Dominant intermediate Charcot-Marie-Tooth type C maps to chromosome 1p34-p35.

  2003cited by this paper
• Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease.

  2003cited by this paper
• Mutations in the ganglioside-induced differentiation-associated protein-1 (GDAP1) gene in intermediate type autosomal recessive Charcot-Marie-Tooth neuropathy.

  2003cited by this paper
• Dynamin2 and cortactin regulate actin assembly and filament organization.

  2002cited by this paper
• Reduction in the minimum candidate interval in the dominant-intermediate form of Charcot-Marie-Tooth neuropathy to D19S586 to D19S432

  2002cited by this paper
• Dominant intermediate Charcot-Marie-Tooth neuropathy maps to chromosome 19p12-p13.2.

  2001influential reference
• Localization of the gene for the intermediate form of Charcot-Marie-Tooth to chromosome 10q24.1-q25.1.

  2001cited by this paper
• Nomenclature for the description of human sequence variations

  2001cited by this paper
• Dynamin and its role in membrane fission.

  2000cited by this paper
• Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia.

  2000cited by this paper
• Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis

  1999cited by this paper
• The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype.

  1999cited by this paper
• Dynamin : A Molecular Motor

  1998cited by this paper
• Charcot-Marie-Tooth disease: an intermediate form.

  1998cited by this paper
• The dynamins: redundant or distinct functions for an expanding family of related GTPases?

  1997cited by this paper
• Hereditary motor and sensory neuropathies.

  1991cited by this paper
• Hereditary motor and sensory neuropathy type II. Clinicopathological study of a family.

  1986cited by this paper
• Adult polyglucosan body disease: Clinical and nerve biopsy findings in two cases

  1983cited by this paper
• The clinical features of hereditary motor and sensory neuropathy types I and II.

  1980cited by this paper
• The peroneal muscular atrophy syndrome: clinical, genetic, electrophysiological and nerve biopsy studies. I. Clinical, genetic and electrophysiological findings and classification.

  1978cited by this paper
• The peroneal muscular atrophy syndrome. Clinical, genetic, electrophysiological and nerve biopsy studies. Part 2. Observations on pathological changes in sural nerve biopsies.

  1977cited by this paper
• Infantile Globoid Cell Leucodystrophy (Krabbe's Disease) – Some remarks on clinical, biochemical and sural nerve biopsy findings

  1974cited by this paper
• Infantile globoid cell leucodystrophy (Krabbe's disease). Some remarks on clinical, biochemical and sural nerve biopsy findings.

  1974cited by this paper
• Infantile globoid cell leucodystrophy (Krabbe's disease).

  1971cited by this paper
• Centronuclear ("myotubular") myopathy.

  1969cited by this paper
• Dynamin and Its Role in Membrane Fission

  year unknowncited by this paper

• DNM2-CMT neuropathy stems from disrupted Schwann cell function and shows limited therapeutic reversibility

  2025cites this paper
• BIN1 reduction ameliorates DNM2-related Charcot–Marie–Tooth neuropathy

  2025cites this paper
• Muscle-Specific DNM2 Overexpression Improves Charcot–Marie–Tooth Disease In Vivo and Reveals a Narrow Therapeutic Window in Skeletal Muscle

  2025cites this paper
• Dynamins in human diseases: differential requirement of dynamin activity in distinct tissues.

  2023cites this paper
• Mutational screening of Greek patients with axonal Charcot‐Marie‐Tooth disease using targeted next‐generation sequencing: Clinical and molecular spectrum delineation

  2023cites this paper
• Congenital neutropenia: from lab bench to clinic bedside and back.

  2023cites this paper
• A Novel Dynamin 2 Mutation Causing Dominant Intermediate Charcot-Marie-Tooth Neuropathy: Case Report

  2022cites this paper
• Myopathies distales

  2022cites this paper
• Analysis of trio test in neurodevelopmental disorders

  2022cites this paper
• Introduction sur les aspects génétiques des neuropathies

  2022cites this paper
• Hereditary myopathies associated with hematological abnormalities

  2022cites this paper
• Dynamin-2 deficiency causes age- and sex-dependent neutropenia and myelodysplasia in mice

  2022cites this paper
• Miopatie distali

  2022cites this paper
• Genetic Neuropathy Due to Impairments in Mitochondrial Dynamics

  2021cites this paper
• Elevated Creatinine Kinase in Peripheral Neuropathy Is Associated With Muscle Cramping

  2021cites this paper
• Molecular Mechanisms behind Inherited Neurodegeneration of the Optic Nerve

  2021cites this paper
• A new mutation in DNM2 gene in a large Italian family

  2021cites this paper
• The Maintenance of Mitochondrial DNA Integrity and Dynamics by Mitochondrial Membranes

  2020influential citation
• Congenital Neutropenia

  2020cites this paper
• Mice carrying an analogous heterozygous dynamin 2 K562E mutation that causes neuropathy in humans develop predominant characteristics of a primary myopathy

  2020influential citation
• A Patient with Neonatal Cholestasis

  2020cites this paper
• Dynamin Superfamily at Pre- and Postsynapses: Master Regulators of Synaptic Transmission and Plasticity in Health and Disease

  2020cites this paper
• De Novo and Inherited Variants in GBF1 are Associated with Axonal Neuropathy Caused by Golgi Fragmentation

  2020cites this paper
• Panorama of the distal myopathies

  2020cites this paper
• Physiological impact and disease reversion for the severe form of centronuclear myopathy linked to dynamin

  2020cites this paper
• Correlative SICM-FCM reveals changes in morphology and kinetics of endocytic pits induced by disease-associated mutations in dynamin

  2019influential citation
• Different in vivo impact of Dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or Centronuclear Myopathy.

  2019cites this paper
• Schwann cells, but not Oligodendrocytes, Depend Strictly on Dynamin 2 Function

  2019cites this paper
• Disruption of genes associated with Charcot-Marie-Tooth type 2 lead to common behavioural, cellular and molecular defects in Caenorhabditis elegans

  2019cites this paper
• Insights into wild type dynamin 2 and the consequences of DNM2 mutations from transgenic zebrafish.

  2019cites this paper
• The characterisation of dynamin-like proteins in the gastric pathogen Helicobacter pylori

  2018cites this paper
• Phenotype variability and histopathological findings in patients with a novel DNM2 mutation

  2018cites this paper
• Dynamins 2 and 3 control the migration of human megakaryocytes by regulating CXCR4 surface expression and ITGB1 activity.

  2018cites this paper
• Intermediate Charcot–Marie–Tooth disease: an electrophysiological reappraisal and systematic review

  2017cites this paper
• Revista Española de Cirugía Ortopédica y Traumatología

  2016cites this paper
• Clinical, neurophysiological and morphological study of dominant intermediate Charcot-Marie-Tooth type C neuropathy

  2016cites this paper
• Towards a functional pathology of hereditary neuropathies

  2016cites this paper
• Impaired dynamin 2 function leads to increased AP-1 transcriptional activity through the JNK/c-Jun pathway.

  2016cites this paper
• Dynamin 2‐Dependent Endocytosis is Required For Normal Megakaryocyte Development

  2015cites this paper
• The coexistence of dynamin 2 mutation and multiple mitochondrial DNA (mtDNA) deletions in the background of severe cardiomyopathy and centronuclear myopathy.

  2015cites this paper
• Distribución mutacional y correlación genotipo-fenotipo del síndrome de Charcot-Marie-Tooth en la Comunidad Valenciana.

  2015cites this paper
• Adult-onset autosomal dominant spastic paraplegia linked to a GTPase-effector domain mutation of dynamin 2

  2015cites this paper
• Progressive Neuromuscular Syndromes Linked to Dynamin-2 Mutations

  2015influential citation
• PLATELETS AND THROMBOPOIESIS Dynamin 2 – dependent endocytosis is required for normal megakaryocyte development in mice

  2015cites this paper
• Mitochondrial dynamics and inherited peripheral nerve diseases.

  2015cites this paper
• Charcot-Marie-Tooth Diseases

  2014cites this paper
• Mitochondrial Dynamics in Peripheral Neuropathies

  2014influential citation
• Dynamin‐2 in nervous system disorders

  2014cites this paper
• Corrélations génotype/phénotype dans la maladie de Charcot-Marie-Tooth : l'exemple des mutations du gène INF2

  2014cites this paper
• Dominant and recessive intermediate CMT (CMTDI and CMTRI)

  2014cites this paper
• Intermediate Charcot-Marie-Tooth disease

  2014cites this paper
• Neuropathologic characterization of INF2-related Charcot-Marie-Tooth disease: evidence for a Schwann cell actinopathy.

  2014cites this paper
• Hereditary motor-sensory, motor, and sensory neuropathies in childhood.

  2013cites this paper
• Overlapping molecular pathological themes link Charcot-Marie-Tooth neuropathies and hereditary spastic paraplegias.

  2013cites this paper
• Centronuclear myopathy related to dynamin 2 mutations: Clinical, morphological, muscle imaging and genetic features of an Italian cohort

  2013cites this paper
• Early onset (childhood) monogenic neuropathies.

  2013cites this paper
• Genetik der Neuropathien

  2013cites this paper
• Dominant Charcot-Marie-Tooth syndrome and cognate disorders.

  2013cites this paper
• Oligomerization of dynamin superfamily proteins in health and disease.

  2013cites this paper
• DNA testing in hereditary neuropathies.

  2013cites this paper
• Identification of a Location at Chromosome 19p in a Big Chinese Family with Charcot-Marie-Tooth Disease

  2013cites this paper
• Mécanodétection des forces hémodynamiques lors du développement endocardique chez l'espèce Danio rerio

  2013cites this paper
• Neuromuscular Disease: A Case-Based Approach: Index

  2013cites this paper
• The use of endocapsular equator rings for preventing posterior capsule opacification.

  2012cites this paper
• [Non-fortuitous dynamin II mutation-related association: neutropenia and Charcot-Marie-Tooth disease].

  2012cites this paper
• Replacement of Arg-386 with Gly in Dynamin 1 Middle Domain Reduced GTPase Activity and Oligomer Stability in the Absence of Lipids

  2012cites this paper
• Structural and functional characterization of interactions of myotubularin-related proteins

  2012cites this paper
• Disorders of Peripheral Nerves

  2012cites this paper
• Neurogenetics: A Guide for Clinicians

  2012cites this paper
• Rapid formation and resolution of cataracts following orthopedic surgery for a patient with Charcot-Marie-Tooth disease.

  2012cites this paper
• Dynamin 2 mutations in Charcot-Marie-Tooth neuropathy highlight the importance of clathrin-mediated endocytosis in myelination.

  2012cites this paper
• Mutation spectrum in the large GTPase dynamin 2, and genotype–phenotype correlation in autosomal dominant centronuclear myopathy

  2012cites this paper
• Neurogenetics: Charcot–Marie–Tooth diseases

  2012cites this paper
• Etiological Role of Dynamin in Charcot-Marie-Tooth Disease

  2012cites this paper
• Dynamin 2 in Charcot-Marie-Tooth disease.

  2012cites this paper
• [Guidelines for molecular diagnosis of Charcot-Marie-Tooth disease].

  2012cites this paper
• Guía diagnóstica en el paciente con enfermedad de Charcot-Marie-Tooth

  2012cites this paper
• Hereditary peripheral neuropathies of childhood: an overview for clinicians.

  2011cites this paper
• Congenital neutropenia: diagnosis, molecular bases and patient management

  2011cites this paper
• Mild Functional Differences of Dynamin 2 Mutations Associated to Centronuclear Myopathy and Charcot-Marie-Tooth Peripheral Neuropathy

  2011cites this paper
• Enfermedad de Charcot-Marie-Tooth: revisión con énfasis en la fisiopatología del pie cavo

  2011cites this paper
• Charcot-Marie-Tooth disease: a review with emphasis on the pathophysiology of pes cavus

  2011cites this paper
• Charcot–Marie–Tooth Disease and Associated Peripheral Neuropathies

  2011cites this paper
• Axonal Charcot-Marie-Tooth disease.

  2011cites this paper
• Characterization of two mutations in the SPTLC1 subunit of serine palmitoyltransferase associated with hereditary sensory and autonomic neuropathy type I

  2011cites this paper
• Recent Advances in the Genetics of Hereditary Axonal Sensory-Motor Neuropathies Type 2

  2011cites this paper
• Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in a patient with antiphospholipid antibodies and Charcot-Marie-Tooth disease.

  2011cites this paper
• Phenotypic Variability in a Large Czech Family with a Dynamin 2–Associated Charcot-Marie-Tooth Neuropathy

  2011influential citation
• Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy.

  2010cites this paper
• Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibers due to a DNM2 mutation.

  2010cites this paper
• Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies.

  2010cites this paper
• Clinical characterization and genetic analysis of a possible novel type of dominant Charcot-Marie-Tooth disease.

  2010cites this paper
• Enfermedad de Charcot-Marie-Tooth: Estudio clínico y molecular de los genes GJB-1 y MFN2 en la población española.

  2010cites this paper
• Dynamic instability of microtubules regulated by Dynamin2 and Charcot-Marie-Tooth disease

  2010cites this paper
• Dynamin 2 and human diseases

  2010cites this paper
• Dynamin 2 and human disease

  2009influential citation